Search Results 1361-1370 of 22063 for Inhibition
... inhibitors, patients with colon cancer should have received at least 2 prior lines of therapy with a fluoropyrimidine in combination with oxaliplatin and ...
Dasatinib is in a class of medications called tyrosine kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells ...
Both are being studied in clinical trials and have resulted in licensing opportunities under multiple patents. Pan-HDAC inhibitors are a class of drugs that ...
"That same basic approach was used 25 years ago to come up with HIV protease inhibitors ... inhibitor." Dr. Badley is an infectious disease specialist at ...
... inhibitor (ICIs) since the time of first being diagnosed with uveal melanoma. Patients who had previously received immune checkpoint inhibition for a prior ...
DeVault says, despite the risks, proton pump inhibitors are the best option for some patients with heartburn. However, he thinks the medications are over ...
Prior therapy with immune checkpoint inhibitors (e.g., anti-CTLA4, anti-PD-1 ... In case of a checkpoint inhibitor: a minimal interval of 4 months ...
... inhibitors, methylxanthines, or a combination of short acting beta-2-agonist and short acting muscarinic antagonist). Note: Subjects must be willing to stay ...
Oral immunomodulatory agents other than AZA, 6-MP, or MTX (e.g., Janus kinase [JAK] inhibitors, 6-thioguanine [6-TG], cyclosporine, tacrolimus, sirolimus ...
Currently receiving other interleukin (IL)-1 or IL-6 blockers, janus-activating kinase (JAK) or tumor necrosis factor (TNF) inhibitors. Has a history of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!